N-3 Fatty acids as resolvents of inflammation in the A549 cells

Pharmacological Reports

Volumn 67, Issue 3, 2015, Pages 610-615

  Gdula Argasińska, Joanna ^a   Czepiel, Jacek ^a   Woźniakiewicz, Aneta ^b   Wojtoń, Katarzyna ^a   Grzywacz, Agata ^a   Woźniakiewicz, Michał ^b   Jurczyszyn, Artur ^c   Perucki, William ^d   Librowski, Tadeusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

COX 2; Fatty acids; FP receptor; Maresin; Protectin D1

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ARACHIDONIC ACID; CD59 ANTIGEN; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LIPOPOLYSACCHARIDE; MARESIN; MEMBRANE LIPID; PROSTAGLANDIN F2 ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR; PROTECTIN D1; PROTEIN; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; OMEGA 3 FATTY ACID;

A549 CELL LINE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFLAMMATION; PROTEIN EXPRESSION; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; METABOLISM; TUMOR CELL LINE;

ANTI-INFLAMMATORY AGENTS; CELL LINE, TUMOR; CELL MEMBRANE; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 84925280696     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.01.001     Document Type: Article

References (39)

1. R.A. Colas, M. Shinohara, J. Dalli, N. Chiang, and C.N. Serhan Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue Am J Physiol Cell Physiol 307 1 2014 C39 C54
2. M. Spite, J. Clária, and C.N. Serhan Resolvins: specialized proresolving lipid mediators, and their potential roles in metabolic diseases cell metabolism Cell Metab 19 1 2014 21 36
3. B.D. Levy, and C.N. Serhan Resolution of acute inflammation in the lung Ann Rev Physiol 76 2014 467 492
4. C.N. Serhan, and N.A. Petasis Resolvins and protectins in inflammation resolution Chem Rev 111 10 2011 5922 5943
5. H. Wang, T.O. Khor, C.L. Saw, W. Lin, T. Wu, and Y. Huang, et al. Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid Mol Pharm 7 6 2010 2185 2193
6. J.Z. Nowak Oxidative stress, polyunsaturated fatty acids derived oxidation products and bis-retinoids as potential inducers of CNS diseases: focus on age-related macular degeneration Pharmacol Rep 65 2 2013 288 304
7. X. Li, Y. Yu, and C.D. Funk Cyclooxygenase-2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4) FASEB J 27 12 2013 4987 4997
8. J. Davidson, D. Rotondo, M.T. Rizzo, and H.A. Leaver Therapeutic implications of disorders of cell death signaling: membranes, micro-environment, and eicosanoid and docosanoid metabolism Br J Pharmacol 166 4 2012 1193 1210
9. E.R. Greene, S. Huang, C.N. Serhan, and D. Panigrahy Regulation of inflammation in cancer by eicosanoids Prostaglandins Other Lipid Med 96 1-4 2011 27 36
10. M. Dessi, A. Noce, P. Bertucci, S. Manca di Villahermosa, R. Zenobi, and V. Castagnola Atherosclerosis, dyslipidemia, and inflammation: the significant role of polyunsaturated fatty acids ISRN Inflamm 2013 2013 191823
11. P.C. Norris, and E.A. Dennis A lipidomic perspective on inflammatory macrophage eicosanoid signaling Adv Biol Regul 54 2014 99 110
12. R. Wall, R.P. Ross, G.F. Fitzgerald, and C. Stanton Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids Nutr Rev 68 5 2010 280 289
13. E. Patterson, R. Wall, G.F. Fitzgerald, R.P. Ross, and C. Stanton Health implications of high dietary omega-6 polyunsaturated fatty acids J Nutr Metab 2012 2012 539426
14. M. Gao, L. Chen, L. Yang, X. Yu, J. Kou, and B. Yu Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-κB/p65: Akt and MAPK pathway in THP-1 cells Pharmacol Rep 66 3 2014 480 484
15. A.R. Chopade, F.J. Sayyad, and N.S. Naikwade Pharmacological characterization of carrageenan induced heat muscle hyperalgesia in rats using non-selective: preferential and selective COX-2 inhibitors Pharmacol Rep 66 3 2014 353 362
16. M. Siwek, M. Sowa-Kućma, D. Dudek, K. Styczeń, B. Szewczyk, and K. Kotarska, et al. Oxidative stress markers in affective disorders Pharmacol Rep 65 6 2013 1558 1571
17. J. Graham Purification of human erythrocyte 'ghosts' J.R. Harris, J. Graham, D. Rickwood, Cell biology protocols 2006 John Wiley & Sons, Ltd. Chichester, UK 137 138
18. J. Folch, M. Lees, and G.H.S. Stanley A simple method for the isolation and purification of total lipids from animal tissue J Biol Chem 226 1 1957 497 509
19. W.R. Morrison, and L.M. Smith Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol J Lipid Res 5 1964 600 608
20. A. Jurczyszyn, J. Czepiel, J. Gdula-Argasińska, A. Czapkiewicz, G. Biesiada, and M. Drózdz, et al. Erythrocyte membrane fatty acids in multiple myeloma patients Leuk Res 38 10 2014 1260 1265
21. J. Gdula-Argasińska, A. Garbacik, M. Tyszka-Czochara, M. Woźniakiewicz, P. Paśko, and J. Czepiel Identification of lipid derivatives in Hep G2 cells Acta Biochim Pol 60 4 2013 811 815
22. M. Lieber, B. Smith, A. Szakal, W. Nelson-Rees, and G. Todaro A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells Int J Cancer 17 1 1976 62 70
23. A.V. Andreeva, M.A. Kutuzov, and T.A. Voyno-Yasenetskaya Regulation of surfactant secretion in alveolar type II cells Am J Physiol Cell Mol Physiol 293 2 2007 L259 L271
24. J. Nowak Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids Postepy Hig Med Dosw 64 2010 115 132
25. H. Du, X. Chen, J. Zhang, and C. Chen Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ Br J Pharmacol 163 7 2011 1533 1549
26. I. Demiryilmaz, M.I. Turan, A. Kisaoglu, M. Gulapoglu, I. Yilmaz, and H. Suleyman Protective effect of nimesulide against hepatic ischemia/reperfusion injury in rats: effects on oxidant/antioxidants, DNA mutation and COX-1/COX-2 levels Pharmacol Rep 66 4 2014 647 652
27. G. Schmitz, and J. Ecker The opposing effects of n-3 and n-6 fatty acids Prog Lipid Res 47 2 2008 147 155
28. T.D. Mickleborough, S.L. Tecklenburg, G.S. Montgomery, and M.R. Lindley Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells Clin Nutr 28 1 2009 71 77
29. A. Saedisomeolia, L.G. Wood, M.I. Garg, P.G. Gibson, and P.A. Wark Anti-inflammatory effects of long-chain n-3 PUFA in rhinovirus-infected cultured airway epithelial cells Br J Nutr 101 4 2009 533 540
30. C.L. Saw, Y. Huang, and A.N. Kong Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid Biochem Pharmacol 79 3 2010 421 430
31. M. Murakami, H. Naraba, T. Tanioka, N. Semmyo, Y. Nakatani, and F. Kojima, et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2 J Biol Chem 275 42 2000 32783 32792
32. D.F. Legler, M. Bruckner, E. Uetz-von Allmen, and P. Krause Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances Int J Biochem Cell Biol 42 2 2010 198 201
33. P. Wortman, Y. Miyazaki, N.S. Kalupahana, S. Kim, M. Hansen-Petrik, and A.M. Saxton n3 and n6 polyunsaturated fatty acids differentially modulate prostaglandin E secretion but not markers of lipogenesis in adipocytes Nutr Metab (Lond) 6 5 2009 1 10 http://www.nutritionandmetabolism.com/content/6/1/5
34. W.L. Song, G. Paschos, S. Fries, M.P. Reilly, Y. Yu, and Y. Rokach, et al. Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation J Biol Chem 284 35 2009 23636 23643
35. P. Singer, H. Shapiro, M. Theilla, R. Anbar, J. Singer, and J. Cohen Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective Intensive Care Med 34 9 2008 1580 1592
36. J.D. Brooks, G.L. Milne, H. Yin, S.C. Sanchez, N.D. Porter, and J.D. Morrow Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid J Biol Chem 283 18 2008 12043 12055
37. C. Stryjecki, K. Roke, S. Clarke, D. Nielsen, A. Badawi, and A. El-Sohemy, et al. Enzymatic activity and genetic variation in SCD1 modulate the relationship between fatty acids and inflammation Mol Genet Metab 105 3 2012 421 427
38. X. Rong, C.J. Albert, C. Hong, M.A. Duerr, B.T. Chamberlain, and E.J. Tarling, et al. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition Cell Metab 18 5 2013 685 697
39. H.H. Tai, C.M. Ensor, M. Tong, H. Zhou, and F. Yan Prostaglandin catabolizing enzymes Prostaglandins Other Lipid Mediat 68-69 2002 483 493